Hepatitis C Stocks

Description:

This portfolio consists of public companies that are researching a cure for Hepatitis C which affects 170 million people worldwide

"The hottest area in drug development right now and for the next couple of years is hepatitis C," said Kris Jenner, whow runs the $1.7 billion T. Rowe Price Health Sciences Fund.
Portfolio not tracked.

Most Viewed Portfolios

View All

Articles

A Small Stocks to Play the Ukraine Crisis

04.16.14 | 02:17 PM

DELAFIELD, Wis. (Stockpickr) -- Energy has some energy in this shaky equity market. >>5 Stocks Set to Soar on Bullish Earnings In contrast to al...

5 Stocks Insiders Love Right Now

04.16.14 | 01:08 PM

DELAFIELD, Wis. (Stockpickr) -- Corporate insiders sell their own companies' stock for a number of reasons. >>5 Stocks Set to Soar on Bullish Ear...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter